Home DoctorHui Completes RMB 30 Million Series A+ Funding Round and Expands into Offline Healthcare Services

DoctorHui Completes RMB 30 Million Series A+ Funding Round and Expands into Offline Healthcare Services

Oct 31, 2016 11:18 CST Updated 11:18

VCBeat (WeChat ID: vcbeat) has learned that Yishenghui recently announced the completion of its RMB 30 million Series A+ financing round. (Related reading:Doctor Hui: The “YY + Zhihu” of the Medical Field


“Doctor Hub” is a “comprehensive-content physician community” app under Yiyang Technology, designed specifically for doctors. It was developed through continuous upgrades and enhancements based on the functionalities of Yiyang Technology’s other WeChat-based product, “Medical V Live.” Although Yiyang Technology has been established for only one year, it has rapidly completed three rounds of financing. In terms of both funding volume and speed, the company ranks among the leaders in the internet healthcare industry.


1466486767723468.jpg

Pictured are Wang Jue (left) and Wang Siyang (right).


Yi Yang Technology CEO Wang Jue has always firmly believed that online physician communities are an excellent entry point for internet healthcare. In his view, there are currently three main approaches to entering the internet healthcare market: targeting the demand side (from the patient’s perspective); targeting the supply side (from the perspective of physicians and hospitals); and facilitating matchmaking between healthcare supply and demand. The “three giants” of China’s internet healthcare sector—WeDoctor, DXY, and Chunyu Doctors—are typical representatives of these three respective approaches. However, healthcare is a supply-driven market, and the low-frequency nature of demand-side interactions is difficult to change. Since the internet is best suited for high-frequency, standardized scenarios, targeting the relatively higher-frequency supply side represents the most viable approach for leveraging internet technologies in healthcare.


The Medical V Live Streaming (Yishenghui) team was established in September 2015, nearly a year later than its competitors. In late November of the same year, “Medical V Live Streaming,” operating via WeChat and PC channels, officially launched. After more than six months of operation, Medical V Live Streaming has transformed from a niche physician community into a comprehensive one, maintaining a frequency of four medical-themed live broadcasts per day. It rapidly gained a large user base and positive market reception, achieving rapid growth and overtaking industry peers in a short period.


However, Wang Jue and his team soon realized that while live streaming was a critical need for physician users, it imposed an excessively heavy user experience. Consequently, they gradually incorporated micro-content tailored for physicians, such as text-and-image posts, case studies, and medical notes, thereby making the product format more diverse and multidimensional. DoctorHui successfully completed its transformation from a single-function physician live-streaming platform into a comprehensive content-driven physician community.


DoctorHui currently operates across three major platforms: PC, WeChat, and mobile app. The platform has 400,000 registered physicians, with a daily active user rate of approximately 10%, establishing it as a leading physician community in China.


Having established a firm foothold in the physician community, Yiyang Technology has begun to actively expand into offline healthcare services. “While the physician community represents an excellent strategic position, it serves merely as an entry point. The broader healthcare market lies in the offline sector, where our true competitive advantages also reside,” stated Wang Jue. Unlike many founders in the internet healthcare space, the two founders of Yiyang Technology come from the pharmaceutical industry and possess extensive expertise in the pharmaceutical sector.


Founder Wang Siyang hails from Holly Group, a private enterprise based in Zhejiang. His family holds controlling stakes in two of China’s top 100 listed pharmaceutical companies: Kunming Pharmaceutical Corp. and Jianmin Pharmaceutical Group. The other founder and CEO, Wang Jue, also comes from a third-generation family with deep roots in the pharmaceutical industry. Both founders and their team possess extensive hands-on experience in the industry. The company has already begun expanding its offline medical services, which will be a key strategic focus for Yiyang Technology following its recent financing round.